7.68 USD
↗ 0.04 (0.47%)LIVE (AS OF 11:41 AM EDT)
Seres Therapeutics, Inc.
MCRBNASDAQ • USD
Market: OPEN
Open?$7.53
High?$7.75
Low?$7.37
Prev. Close?$7.64
Volume?16.9K
Avg. Volume?49.6K
VWAP?$7.58
Rel. Volume?0.34x
Bid / Ask
Bid?$6.39 × 100
Ask?$8.99 × 100
Spread?$2.60
Midpoint?$7.69
Valuation & Ratios
Market Cap?74.0M
Shares Out?9.7M
Float?6.6M
Float %?72.7%
P/E Ratio?N/A
P/B Ratio?2.79
EPS?-$4.84
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.
Employees
66
Market Cap
74.0M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2015-06-26
Address
200 SIDNEY STREET
CAMBRIDGE, MA 02139
Phone: 617 945 9626
CAMBRIDGE, MA 02139
Phone: 617 945 9626
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?1.65Adequate
Quick Ratio?1.65Adequate
Cash Ratio?1.54Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUED
Score67/100
P/E?N/A▾
P/B?2.79CHEAP▾
P/S?64.50HIGH▾
P/FCF?N/A▾
EV/EBITDA?-0.5CHEAP▾
EV/Sales?38.49HIGH▾
Returns & Efficiency
ROE?-177.0%WEAK▾
ROA?-39.9%WEAK▾
Cash Flow & Enterprise
FCF?$-42371000
Enterprise Value?$44.2M
Fundamentals ratios updated end of day